Secure CheckoutPersonal information is secured with SSL technology.
Free ShippingFree global shipping
No minimum order.
Fighting the Opioid Epidemic: The Role of Providers and the Clinical Laboratory in Understanding Who is Vulnerable covers the important aspects that are essential in fighting the opioid epidemic. This succinct reference highlights how the toxicology laboratory can play a vital role in fighting the opioid epidemic by implementing a robust system for drugs of abuse testing as well as drug testing in pain management patients. It targets health care professionals in a technical manner, discussing polymorphisms of important genes that may be associated with increased vulnerability of alcohol and drug addiction to an individual.
- Covers all important aspects of opioid abuse, including genetic and environmental factors
- Discusses pharmacology, toxicology and the pharmacogenomics related to opioid metabolism
- Presents genetic and environmental factors associated with those vulnerable to opioid addiction, as well as the pitfalls of drug testing in pain management
Clinical pathologists, toxicologists, and physicians practicing pain management
- Opium abuse: past and present
2. Heroin the first designer drug
3. Prescription opioids: use and abuse
4. Pharmacogenetic factors affecting efficacy of opioid therapy in pain management
5. Mixing opioids with alcohol: a dangerous combination
6. Environmental factors linked to drug (including opioids) and alcohol abuse
7. Genetic factors that may make an individual susceptible to drug and alcohol abuse
8. Introduction to drugs of abuse testing
9. Pitfalls of drug testing in pain management
- No. of pages:
- © Elsevier 2020
- 1st August 2020
- Paperback ISBN:
Amitava Dasgupta received his PhD degree in Chemistry from Stanford University and his fellowship training in Clinical Chemistry from the Laboratory Medicine Department of the University of Washington School of Medicine at Seattle. He is a tenured Full Professor of Pathology and Laboratory Medicine at the University of Texas Health Sciences Center located at the Texas Medical Center at Houston. Dr. Dasgupta has published 210 scientific papers, written many invited review articles, and has edited, co-edited or written 15 books. He is on the Editorial Board of five major medical journals including American Journal of Clinical Pathology, Archives of Pathology and Laboratory Medicine, Therapeutic Drug Monitoring, Clinica Chimica Acta and Journal of Clinical Laboratory Analysis.
Professor, Pathology and Laboratory Medicine, McGovern Medical School, The University of Texas, Houston, TX, USA